Articles

February 19, 2020 Making Strides in Gender Parity Alnylam ranked #3 in gender parity and #1 in fair representation for Women of Color (WOC) in Executive and Board Leadership among the top 25 employers in MA. Read More ›
January 9, 2020 Expressing the Puzzling Challenges of hATTR Amyloidosis Through Art We recently spoke with Peggy and her life partner Dan, who is living with hATTR amyloidosis, about their submission, At the Coffee Shop.  Read More ›
December 12, 2019 Building Bridges to Support Patients’ Care Supporting patients and their caregivers by facilitating access to innovative treatments is at the core of our Patient Access Philosophy. Read More ›
December 4, 2019 Guest Post: Partnering to Educate the African American Community About hATTR Amyloidosis One of our areas of focus at Black Health Matters is education about the importance of knowing one’s family health history. Read More ›
November 18, 2019 Building a Culture of Passion and Commitment Kelley Boucher, SVP/Chief Human Resources Officer, discusses Alnylam being named to The Boston Globe's 2019 Best Places to Work List... Read More ›
November 18, 2019 Alnylam Named a Boston Globe Top Place to Work for 5th Year in a Row We're thrilled to be named a Top Places to Work for 2019 by The Boston Globe in the "Large Employer" category, marking our fifth year in a row on the list.  Read More ›
November 5, 2019 A Truly Special Place for Science Recently, our company was named Science Magazine’s Top Employer for 2019 – a significant achievement in the scientific community and a true milestone... Read More ›
October 25, 2019 Alnylam Named #1 Biopharma Employer by Science Magazine Alnylam has been named the #1 science employer in biopharma for 2019 by Science Magazine and Science Careers. This is our first appearance on the list. Read More ›
October 1, 2019 The Importance of Ensuring Quality in a New Class of Medicines In Product Quality, we have a truly big picture view of the medicines we’re making to ensure they are compliant with good manufacturing practices and... Read More ›
October 1, 2019 Building for Our Future Why would a company without a commercially approved medicine decide to build a significant manufacturing facility? Why not continue to rely on contract... Read More ›
Subscribe to Articles

Get In Touch

Have any questions or comments about the content you see on this page?

You are now leaving Alnylam.com

The following content may not be associated with Alnylam Pharmaceuticals.

Links to all outside sites are provided as a reference for our visitors.

Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.

Proceed to Site